Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
38 hedge funds and large institutions have $91.5M invested in Sorrento Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 6 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
144% more capital invested
Capital invested by funds: $37.5M → $91.5M (+$54M)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
15% more funds holding
Funds holding: 33 → 38 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.8M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.08M |
| 3 |
Morgan Stanley
New York
|
+$596K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$441K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$420K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$2.44M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
-$2.13M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.92M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$928K |
| 5 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$514K |
SRNE Hedge Fund Activity: Q4 2014 in Review
38 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q4 2014, worth a combined $91.5M — up 144% from $37.5M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new SRNE positions and 6 closed out — a net gain of 6 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Cormorant Asset Management, adding an estimated $3.8M. The largest seller was JP Morgan Chase, cutting an estimated $2.44M.
- 38 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q4 2014, up from 33 in Q3 2014.
- Funds reported $91.5M of Sorrento Therapeutics, Inc. stock for Q4 2014, up 144% quarter-over-quarter.
- 12 funds opened new Sorrento Therapeutics, Inc. positions in Q4 2014 and 6 closed out, a net change of +6 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q4 2014 was Cormorant Asset Management, an estimated $3.8M added.
- The largest Sorrento Therapeutics, Inc. seller in Q4 2014 was JP Morgan Chase, an estimated $2.44M sold.
Based on aggregated 13F filings for Q4 2014.